Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04602312
Other study ID # 2019000347-S4C
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 28, 2020
Est. completion date September 26, 2021

Study information

Verified date January 2022
Source The University of Queensland
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Both mindfulness meditation and expectancy effects are known to reduce anxiety, stress and catastrophizing, but it is unknown whether and how expectancy effects contribute to the overall effect of mindfulness meditation on these outcomes, especially during significant global events such as the coronavirus pandemic. This study includes four interrelated aims that will probe these effects and interactions.


Recruitment information / eligibility

Status Completed
Enrollment 744
Est. completion date September 26, 2021
Est. primary completion date September 26, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - At least 18 years of age - Able to read and understand English Exclusion Criteria: - Recurrent pain (two or more days in the last month) - Chronic pain (pain most days in the last three months) - Incomplete or invalid data (response time < 32 minutes, failing attention checks) - Completing the 20-minute training module in < 18 minutes or > 90 minutes

Study Design


Intervention

Other:
Meditation (1 x 20-minute guided audio training)
Participants will complete a single session of 20-minutes online guided audio-delivered training session of one of the four conditions.

Locations

Country Name City State
Australia Health and Behavioural Sciences Brisbane Queensland

Sponsors (3)

Lead Sponsor Collaborator
The University of Queensland University of California, San Diego, University of Sydney

Country where clinical trial is conducted

Australia, 

Outcome

Type Measure Description Time frame Safety issue
Other Expectancy assessed via self-report questions (0=lowest expectancy, 10=highest expectancy) 40 minutes
Other Reappraisal assessed via the Cognitive Emotion Regulation Questionnaire (CERQ-R; 4=lowest reappraisal, 20=highest reappraisal) 40 minutes
Other Mindful observing assessed via the Five Facet Mindfulness Questionnaire Observing subscale (FFMQ-O; 1=lowest observing, 5=highest observing) 40 minutes
Other Mindful non-reactivity assessed via the Five Facet Mindfulness Questionnaire Non-reacting subscale (FFMQ-NR; 1=lowest non-reactivity, 5=highest non-reactivity) 40 minutes
Other State Mindfulness assessed via the State Mindfulness Survey (SMS; 1=lowest mindfulness, 21=highest mindfulness) 40 minutes
Other State Decentering assessed via the Metacognitive Processes of Decentering - State (MpoD-s; 0=lowest decentering, 3=highest decentering) 40 minutes
Primary Coronavirus-related catastrophizing assessed via a covid-19-related catastrophizing scale (CCS; 0=no catastrophizing, 52=highest catastrophizing, 30+=clinically significant catastrophizing) 40 minutes